Table 4

Comparison of baseline and treatment for low-intensity NPPV (n=13) and high-intensity NPPV (n=15)

BaselineAfter 6 weeks of NPPVDifference (95% CI)p Value
LI-NPPV-Paco2 01.00 h (mm Hg)*61.5±5.858.0±9.4−3.6 (−9.1 to 2.0)0.19
HI-NPPV-Paco2 01.00 h (mm Hg)*63.6±7.749.6±7.8−14.0 (−18.5 to −9.4)<0.001
LI-NPPV-Paco2 12.00 h (mm Hg)†56.4±5.852.7±7.9−3.6 (−8.9 to 1.6)0.16
HI-NPPV-Paco2 12.00 h (mm Hg)†58.0±7.651.8±6.4−6.2 (−9.5 to −2.9)<0.001
LI-NPPV-HCO3 01.00 h (mmol/l)*33.4±2.831.5±2.4−1.9 (−4.5 to 0.5)0.11
HI-NPPV-HCO3 01.00 h (mmol/l)*34.3±3.630.2±3.2−4.1 (−5.8 to −2.4)<0.001
LI-NPPV-HCO3 12.00 h (mmol/l)†32.6±2.730.5±2.3−2.2 (−4.5 to 0.2)0.07
HI-NPPV-HCO3 12.00 h (mmol/l)†33.8±4.930.4±3.6−3.4 (−4.9 to −1.9)<0.001
LI-NPPV-FEV1 (l)0.76±0.290.80±0.370.04 (−0.07 to 0.16)0.44
HI-NPPV-FEV1 (l)0.74±0.290.85±0.390.11 (0.01 to 0.21)0.037
LI-NPPV-VC (l)1.95±0.452.07±0.680.13 (−0.17 to 0.42)0.37
HI-NPPV-VC (l)1.96±0.582.14±0.620.22 (0.06 to 0.39)0.012
LI-NPPV-BDS after 6MWT‡9 (4/10)6 (4/10)0.55
HI-NPPV-BDS after 6MWT‡9 (4/10)4 (3/5)0.014
LI-NPPV-6MWD252±131291±11138.5 (−2.7 to 79.7)0.065
HI-NPPV-6MWD264±129297±12532.9 (−24.3 to 90.1)0.24
LI-NPPV-PImax (kPa)4.8±1.65.1±1.50.37 (−0.59 to 1.33)0.41
HI-NPPV-PImax (kPa)5.0±2.35.6±2.50.53 (−0.2 to 1.3)0.16
LI-NPPV-SRI-SS58.0±14.663.2±18.95.3 (−0.42 to 11.0)0.066
HI-NPPV-SRI-SS55.8±15.562.2±16.36.4 (1.5 to 11.2)0.014
  • Data are presented as mean±SD unless otherwise stated.

  • 6MWT, 6-minute walking test; BDS, Borg dyspnoea scale; FEV1, forced expiratory volume in 1 s; HI-NPPV, high-intensity non-invasive positive pressure ventilation; HCO3, bicarbonate; LI-NPPV, low-intensity non-invasive positive pressure ventilation; Paco2, arterial carbon dioxide tension; PImax, maximal inspiratory mouth occlusion pressure; SRI-SS, Severe Respiratory Insufficiency Questionnaire Summary Score; TLC, total lung capacity; VC, vital capacity.

  • * Blood gases taken during night time non-invasive ventilation.

  • Blood gases taken under spontaneous breathing.

  • Median values with IQR.